Neurotrope, Inc.·4

Apr 16, 5:01 PM ET

Ciraolo Michael 4

4 · Neurotrope, Inc. · Filed Apr 16, 2019

Insider Transaction Report

Form 4
Period: 2019-04-15
Ciraolo Michael
COO and General Counsel
Transactions
  • Award

    Stock Option (right to buy)

    2019-04-15+100,000100,000 total
    Exercise: $5.67Exp: 2029-04-15Common Stock (100,000 underlying)
Footnotes (2)
  • [F1]These securities were issued in connection with the Reporting Person's appointment as a Chief Operating Officer and General Counsel to the Issuer.
  • [F2]25% of the options vest on the date of grant, with the remaining 75% vesting in equal monthly installments over a two year period beginning on April 1, 2019.

Documents

1 file
  • 4
    tv519017_4.xmlPrimary

    OWNERSHIP DOCUMENT